Rising in popularity at rates that are nearly unimaginable, medications like Ozempic, Trulicity, and Victoza have become household names over the last several years. When it comes to these glucagon-like peptide-1 agonists, also known as “GLP-1’s” or semaglutides, the Journal of American Medical Association (JAMA) Health Forum reported that prescription fills for Ozempic or Wegovy increased by more than 400% between January 2021 and December 2023. In this dialogue, experts across medicine, fitness and brain health – each with a strong point of view, and even stronger evidence to back it up – will come together to drive a boldly productive debate about whether or not we should be embracing this “wonder drug,” and will bring to light brand new (and surprising) research about unexpected benefits that may make you reconsider what you thought you knew. Join us.